866-997-4948(US-Canada Toll Free)

Rosetta Genomics, Ltd. (ROSG) - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Nov 2012

Category :

Surgical Equipment

No. of Pages : 40 Pages


Rosetta Genomics, Ltd. (RGL) is a medical device company, based in Israel. The company develops and commercializes new diagnostic and therapeutic products based on group of genes known as microRNAs. It operates through its business segments such as, RG Laboratory Tests, RG Diagnostic Products, RG MicroRNA Technology and RG Therapeutic Products. RGL conducts several diagnostic test development programs in the fields of oncology and womens health. The company has entered into an agreement with Genetic Technologies Limited for the distribution of Rosetta Genomics\' three diagnostic tests. It distributes its products in Australia, New Zealand and Singapore. RGL is headquartered in Rehovot, Israel.

This report is a source for data, analysis and actionable intelligence on the Rosetta Genomics, Ltd. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Key Facts 6
Rosetta Genomics, Ltd. - Major Products and Services 7
Rosetta Genomics, Ltd. Pipeline Products by Equipment Type 8
Rosetta Genomics, Ltd. Pipeline Products by Development Stage 10
Rosetta Genomics, Ltd. Pipeline Products by Therapy Area 12
Rosetta Genomics, Ltd. Pipeline Products by Milestone Summary 14
Body Fluids-Based Diagnostic Test - Cancer 16
Body Fluids-Based Diagnostic Test - Cancer Product Status 16
Body Fluids-Based Diagnostic Test - Cancer Product Description 16
Body Fluids-Based Diagnostic Test - Cancer Product Patent Details 16
Diagnostic Test - Melanoma 17
Diagnostic Test - Melanoma Product Status 17
Diagnostic Test - Melanoma Product Description 17
Product Institution Details 17
microRNA Test - Congestive Heart Failure 18
microRNA Test - Congestive Heart Failure Product Status 18
microRNA Test - Congestive Heart Failure Product Description 18
microRNA Test - Gastric Cancer Recurrence 19
microRNA Test - Gastric Cancer Recurrence Product Status 19
microRNA Test - Gastric Cancer Recurrence Product Description 19
microRNA Test - Gastric Cancer Recurrence Product Milestone 19
microRNA Test - Neurodegenerative Disease 21
microRNA Test - Neurodegenerative Disease Product Status 21
microRNA Test - Neurodegenerative Disease Product Description 21
microRNA Test - Ovarian Cancer 22
microRNA Test - Ovarian Cancer Product Status 22
microRNA Test - Ovarian Cancer Product Description 22
microRNA Test - Ovarian Cancer Product Milestone 22
microRNA Test - Ovarian Cancer Product Patent Details 23
microRNA Test - Preeclampsia 25
microRNA Test - Preeclampsia Product Status 25
microRNA Test - Preeclampsia Product Description 25
miRscreen Test - Colon Cancer 26
miRscreen Test - Colon Cancer Product Status 26
miRscreen Test - Colon Cancer Product Description 26
miRscreen Test - Colon Cancer Product Milestone 26
miRview Meso Prognostic Test 27
miRview Meso Prognostic Test Product Status 27
miRview Meso Prognostic Test Product Description 27
miRview Meso Prognostic Test Product Milestone 27
miRview Test - Bladder Cancer 28
miRview Test - Bladder Cancer Product Status 28
miRview Test - Bladder Cancer Product Description 28
miRview Test - Kidney Cancer 29
miRview Test - Kidney Cancer Product Status 29
miRview Test - Kidney Cancer Product Description 29
Rosetta Genomics, Ltd. - Key Competitors 30
Rosetta Genomics, Ltd. - Key Employees 31
Rosetta Genomics, Ltd. - Locations And Subsidiaries 32
Head Office 32
Recent Developments 33
Rosetta Genomics, Ltd., Recent Developments 33
Oct 11, 2012: Rosetta Genomics Announces Senior Management Changes 33
Jun 06, 2012: Rosetta Genomics Announces Compliance With Continued Listing Requirements Of NASDAQ Capital Market 33
Apr 23, 2012: Rosetta Genomics Receives US Patent Allowance 34
Apr 19, 2012: Rosetta Genomics Receives Key European Patent In Oncology 34
Mar 19, 2012: Rosetta Genomics To Present Multiple Poster Presentations At 101st Annual Meeting Of United States and Canadian Academy of Pathology 35
Nov 04, 2011: Study Published In World Journal of Gastroenterology Shows Potential For microRNAs To Predict Gastric Cancer Recurrence: Rosetta 35
Oct 11, 2011: Rosetta Genomics Restructures To Reduce Operating Expenses And Focus On Commercial Opportunities 36
Jul 26, 2011: Rosetta Genomics Reports Preliminary Data On Discovery Of Blood-Based microRNA Signature For Identification And Stratification Of Heart Failure Patients 37
Jun 01, 2011: Rosetta Genomics Reports Q1 2011 Results 37
May 23, 2011: Rosetta Genomics And Collaborators To Present Data At ASCO 2011 38

Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Table


Rosetta Genomics, Ltd., Key Facts 1
Rosetta Genomics, Ltd. Key Pipeline Products by Equipment Type 1
Rosetta Genomics, Ltd. Key Pipeline Products by Therapy Area 1
Rosetta Genomics, Ltd. Key Pipeline Products by Development Stage 1
Rosetta Genomics, Ltd., Key Facts 6
Rosetta Genomics, Ltd., Major Products and Services 7
Rosetta Genomics, Ltd. Number of Pipeline Products by Equipment Type 8
Rosetta Genomics, Ltd. Pipeline Products by Equipment Type 9
Rosetta Genomics, Ltd. Number of Pipeline Products by Development Stage 10
Rosetta Genomics, Ltd. Pipeline Products by Development Stage 11
Rosetta Genomics, Ltd. Number of Pipeline Products by Therapy Area 12
Rosetta Genomics, Ltd. Pipeline Products by Therapy Area 13
Rosetta Genomics, Ltd. Number of Pipeline Products By Milestone Summary 14
Rosetta Genomics, Ltd. Pipeline Products by Milestone Summary 15
Body Fluids-Based Diagnostic Test - Cancer - Product Status 16
Body Fluids-Based Diagnostic Test - Cancer - Product Description 16
Body Fluids-Based Diagnostic Test - Cancer - Patent Details1 16
Diagnostic Test - Melanoma - Product Status 17
Diagnostic Test - Melanoma - Product Description 17
microRNA Test - Congestive Heart Failure - Product Status 18
microRNA Test - Congestive Heart Failure - Product Description 18
microRNA Test - Gastric Cancer Recurrence - Product Status 19
microRNA Test - Gastric Cancer Recurrence - Product Description 19
microRNA Test - Gastric Cancer Recurrence - Product Milestone 19
microRNA Test - Neurodegenerative Disease - Product Status 21
microRNA Test - Neurodegenerative Disease - Product Description 21
microRNA Test - Ovarian Cancer - Product Status 22
microRNA Test - Ovarian Cancer - Product Description 22
microRNA Test - Ovarian Cancer - Product Milestone 22
microRNA Test - Ovarian Cancer - Patent Details1 23
microRNA Test - Ovarian Cancer - Patent Details2 23
microRNA Test - Preeclampsia - Product Status 25
microRNA Test - Preeclampsia - Product Description 25
miRscreen Test - Colon Cancer - Product Status 26
miRscreen Test - Colon Cancer - Product Description 26
miRscreen Test - Colon Cancer - Product Milestone 26
miRview Meso Prognostic Test - Product Status 27
miRview Meso Prognostic Test - Product Description 27
miRview Meso Prognostic Test - Product Milestone 27
miRview Test - Bladder Cancer - Product Status 28
miRview Test - Bladder Cancer - Product Description 28
miRview Test - Kidney Cancer - Product Status 29
miRview Test - Kidney Cancer - Product Description 29
Rosetta Genomics, Ltd., Key Employees 31

List of Chart


Rosetta Genomics, Ltd. Pipeline Products by Equipment Type 8
Rosetta Genomics, Ltd. Pipeline Products by Development Stage 10
Rosetta Genomics, Ltd. Pipeline Products by Therapy Area 12
Rosetta Genomics, Ltd. Pipeline Products by Milestone Summary 14

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *